8 results match your criteria: "University of Ulsan College of Medicine Ulsan South Korea.[Affiliation]"

Article Synopsis
  • The study evaluated the impact of genetic variations on clinical outcomes in older patients (≥75 years) undergoing percutaneous coronary intervention (PCI) with clopidogrel-based therapy.
  • Patients were categorized into normal, intermediate, and poor metabolizers based on their genotypes, revealing significant differences in 3-year major adverse cardiac events among these groups.
  • The findings indicated that older patients with loss-of-function alleles experienced higher rates of cardiac events and mortality, highlighting the need for tailored antiplatelet strategies in this population.
View Article and Find Full Text PDF

Background: Although age and body mass index (BMI) significantly affect platelet reactivity units and clinical outcomes after percutaneous coronary intervention, there are limited data on the relationship between high on-treatment platelet reactivity (HPR) and clinical outcomes on age and BMI differences. Thus, we investigated the association of HPR with clinical outcomes according to age and BMI.

Methods And Results: The study analyzed 11 714 patients who underwent platelet function tests after percutaneous coronary intervention.

View Article and Find Full Text PDF

Background Cardiac death or myocardial infarction still occurs in patients undergoing contemporary percutaneous coronary intervention (PCI). We aimed to identify adverse clinical and vessel characteristics related to hard outcomes after PCI and to investigate their individual and combined prognostic implications. Methods and Results From an individual patient data meta-analysis of 17 cohorts of patients who underwent post-PCI fractional flow reserve measurement after drug-eluting stent implantation, 2081 patients with available clinical and vessel characteristics were analyzed.

View Article and Find Full Text PDF

Background Although high platelet reactivity (HPR) on clopidogrel is associated with higher ischemic events and lower bleeding events in patients who have undergone percutaneous coronary intervention with drug-eluting stents, the differential risk of HPR in East Asian women versus men is unknown. Methods and Results We compared 11 714 patients enrolled in the PTRG-DES (Platelet Function and Genotype-Related Long-Term Prognosis in Drug-Eluting Stent-Treated Patients With Coronary Artery Disease) Consortium according to sex and the presence/absence of HPR on clopidogrel (defined as ≥252 P2Y12 reactivity units). The primary study end point was major adverse cardiac and cerebrovascular events (MACCEs; comprising all-cause mortality, myocardial infarction, cerebrovascular accident, and stent thrombosis).

View Article and Find Full Text PDF

Background Clopidogrel monotherapy was more effective in reducing the risk of adverse clinical events than aspirin monotherapy in patients who underwent percutaneous coronary intervention (PCI) with drug-eluting stent (DES), according to the HOST-EXAM (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Extended Antiplatelet Monotherapy) trial. However, it remains unknown whether these effects differ based on sex. Methods and Results This was a prespecified secondary analysis of HOST-EXAM in South Korea.

View Article and Find Full Text PDF

Objectives: In general, deviation of the L-strut of the nasal septum is more challenging to correct than the middle and has less favorable results. This study aimed to develop a technique to correct the L-strut while preserving nasal support effectively and introduce the L-septoplasty technique and its effects.

Methods: Patients with caudal and high dorsal septal deviations who underwent the L-septoplasty technique were retrospectively analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • The resistive reserve ratio (RRR) is a new index that measures the vasodilatory capacity of coronary arteries and microvascular circulation by integrating blood flow and pressure data.
  • A study of 1,245 patients showed that RRR is a stronger prognostic tool for predicting clinical outcomes, such as death or heart attack, over five years compared to traditional indices like fractional flow reserve (FFR) and coronary flow reserve (CFR).
  • Specifically, patients with a depressed RRR (less than 3.5) faced a significantly higher risk of negative health outcomes, making RRR a valuable metric for assessing cardiac health.
View Article and Find Full Text PDF

Background Sex-specific differences may influence prognosis after deferred revascularization following fractional flow reserve (FFR) measurement. This study sought to investigate the sex differences in long-term prognosis of patients with deferred revascularization following FFR assessment. Methods and Results A total of 879 patients (879 vessels) with deferred revascularization with FFR >0.

View Article and Find Full Text PDF